Cargando…
Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomas
Neuroblastoma (NB), a tumor of the sympathetic nervous system, is the most common extracranial solid tumor of childhood. We and others have identified distinct patterns of genomic change that underlie diverse clinical behaviors, from spontaneous regression to relentless progression. We first identif...
Autores principales: | Naraparaju, Koumudi, Kolla, Venkatadri, Zhuang, Tiangang, Higashi, Mayumi, Iyer, Radhika, Kolla, Sriharsha, Okawa, Erin R., Blobel, Gerd A., Brodeur, Garrett M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941291/ https://www.ncbi.nlm.nih.gov/pubmed/26895110 http://dx.doi.org/10.18632/oncotarget.7434 |
Ejemplares similares
-
Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma
por: Higashi, Mayumi, et al.
Publicado: (2015) -
CHD5, a Tumor Suppressor Gene Deleted From 1p36.31 in Neuroblastomas
por: Fujita, Tomoyuki, et al.
Publicado: (2008) -
Nanomicellar Lenalidomide–Fenretinide Combination Suppresses Tumor Growth in an MYCN Amplified Neuroblastoma Tumor
por: Orienti, Isabella, et al.
Publicado: (2020) -
A Novel Nanomicellar Combination of Fenretinide and Lenalidomide Shows Marked Antitumor Activity in a Neuroblastoma Xenograft Model
por: Orienti, Isabella, et al.
Publicado: (2019) -
Poloxamer‐linked prodrug of a topoisomerase I inhibitor SN22 shows efficacy in models of high‐risk neuroblastoma with primary and acquired chemoresistance
por: Alferiev, Ivan S., et al.
Publicado: (2022)